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Background: Various maneuvers are commonly used to achieve the ideal operative field necessary for successful 
endoscopic sinus surgery (ESS). There are a few contradictory reports on this subject and the consensus is that 
propofol anesthesia results in a better or similar surgical field and less or similar amount of bleeding than volatile 
anesthesia. The aim of this study was to compare the surgical field in patients in whom intravenous anesthesia is used 
as opposed to balanced general anesthesia.
Methods: Sixty patients undergoing ESS were randomly assigned into three groups, each of which used a different 
type of anesthesia: propofol/remifentanil (PRO/REM) group, sevoflurane/remifentanil (SEV/REM) group, and 
desflurane/remifentanil (DES/REM) group. We aimed to maintain the intraoperative mean blood pressure (MBP) 
at 65 mmHg and the heartrate (HR) at about 75 beats per minute. The quality of visibility of the surgical field was 
graded, using a validated scoring system, 60 minutes after the start of the operation.
Results: All groups had a similar MBP and mean HR at 60 minutes after the operation started. There was no 
significant differences among the three groups for surgical grade score (P = 0.83).
Conclusions: In this comparative study of three anesthetic combinations (PRO/REM, SEV/REM, and DES/REM) in 
patients undergoing ESS with controlled BP and HR, we did not observe any significant differences in the surgical 
grade scores. (Korean J Anesthesiol 2010; 59: 377-382)
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Introduction
    Due to the nature of the space in which endoscopic sinus 
surgery (ESS) is performed, even a little bleeding can adversely 
affect the surgeon’s ability to visualize the region to be operated. 
Increased bleeding results in further difficulties in obtaining an 
adequate surgical field. As a result, the operation become more 
difficult and takes more time.
    Various attempts have been made to improve the surgical 
field, such as positioning the patient in reverse Trendelenburg, 
decongesting the nose, infiltrating the lateral nasal wall with 
lidocaine and epinephrine, or using the hypotensive anesthesia 
technique [1,2].
    There are a few contradictory reports on this subject but the 
consensus is that propofol anesthesia results in a better or 
similar surgical field [2,3] and less or similar amount of bleeding 
[2,4-6] than does volatile anesthesia. The aim of this study was 
to either confirm or repudiate the findings of previous authors 
and to investigate the effects of the three types of anesthesia in 
the surgical field of ESS, with total intravenous anesthesia (TIVA) 
with propofol/remifentanil, balanced general anesthesia with 
sevoflurane/remifentanil and desflurane/remifentanil under 
controlled mean blood pressure (MBP) and heart rate (HR).
Materials and Methods
    With approval from the hospital ethics committee, we 
recruited 60 patients between the ages of 18 and 60 years who 
were American Society of Anesthesiologists physical status 
I and II and were also undergoing elective ESS. The patients 
were randomly assigned to one of three protocols and then 
underwent ESS under general anesthesia performed by a single 
surgeon at a hospital-based surgery center. The exclusion 
criteria included: body mass index (BMI) ≥ 30.0, history of 
alcohol and drug abuse, pregnancy, medication known to 
affect minimum alveolar anesthetic concentration (MAC), 
communication problems, and allergic fungal sinusitis or 
nasal polyposis (>3 polyps). Allergic fungal sinusitis or nasal 
polyposis increases inflammation and vascularity; both of 
these conditions are related to a higher surgical grade score. 
Written consent for the study was obtained from each patient. 
Randomization was achieved through selection of an unmarked 
envelope revealing the study path immediately before 
induction. Patients were assigned by block randomization 
to receive one of three anesthetic combinations (n = 20 
patients each group): TIVA with propofol/remifentanil group 
(PRO/REM), balanced general anesthesia with sevoflurane/
remifentanil group (SEV/REM) and desflurane/remifentanil 
group (DES/REM).
    Thirty minutes before surgery, patients were given 0.2 
mg glycopyrrolate intramuscularly. The clinical monitoring 
included electrocardiography, pulse oximetry, temperature, 
noninvasive blood pressure, and bispectral index monitor (A-
2000 BIS XP, Aspect Medical System Inc., Norwood, MA, USA). 
The patients in the three groups received target concentration 
infusion (TCI, Orchestra
Ⓡ, Base Primea, Fresinius Vial, France) 
for maintenance of anesthesia. The patient’s age and weight 
were entered into the TCI unit so that the target propofol and 
remifentanil concentrations could be set. Remifentanil TCI was 
started at 3 ng/ml. After remifentanil reach target concentration, 
the inhalation groups (SEV/REM and DES/REM) received 
propofol (2.0 sevoflurane 2.0 mg/kg) for induction followed by 
sevoflurane 2.0 vol% or desflurane 5.0 vol%). The PRO/REM 
group received propofol (initial target plasma concentration, 
4.0 μg/ml) for maintence of anesthesia. During induction, the 
patients were ventilated with 100% oxygen. After loss of the 
eyelash reflex and verbal response, a bolus dose of rocuronium 
0.7 mg/kg was administered for muscular paralysis. The trachea 
was intubated and the lungs were mechanically ventilated to 
achieve an end-tidal CO2 concentration of 25-35 mmHg with 
50% N2O in oxygen. The end-tidal sevoflurane and desflurane 
concentrations, as well as the propofol and remifentanil 
maintenance target infusions were adjusted to maintain an 
adequate depth of anesthesia, as judged by clinical signs and 
hemodynamic responses to surgical stimuli, and to maintain 
blood pressure. 
    In the inhalation group, anesthesia was maintained with 
sevoflurane (end-tidal concentrations of 0.8-2.0%) or desflurane 
(end-tidal concentrations of 3.0-6.0%). The target-controlled 
infusion rate of remifentanil was at 1-3 ng/ml. In the PRO/REM 
group, propofol was administered via target-controlled infusion 
to 2-4 μg/ml and remifentanil infusion was set at 1-3 ng/ml. 
    We aimed to maintain the intraoperative MBP at 65 mmHg, 
HR at about 75 beats per minute and bispectral index value 
from 40 to 60. If the systolic blood pressure fell below 75 mmHg, 
a 5 mg bolus of intravenous (IV) ephedrine was given. No other 
drugs were administered to control blood pressure.
    The propofol, sevoflurane, or desflurane was discontinued 
and remifentanil and N2O were stopped right after the 
termination of the surgery. Once respiration and response to 
verbal command were adequate, patients were endotracheally 
extubated.
    In most cases, the syringe device for the propofol infusion 
were set up and present even when the patient was receiving 
inhalation anesthesia. This was to prevent surgeons from 
knowing which kind of method of anesthesia we are providing. 
After 60 minutes from the start of the operation, the surgeon 
provided numerical assessments of the operative conditions 
(primarily in relation to the amount of bleeding and its effect 
on visibility), and identified the sinus being treated. Surgical 379 www.ekja.org
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field was scored using the scale that was originally described 
by Fromme et al. [7] and then subsequently adapted by 
Boezaart et al. [8]. Appendix 1 shows the surgical grade scoring 
system designed specifically for use with ESS. In addition, we 
documented data regarding the extent of the surgery, the Lund-
Mackay (LM) computed tomography (CT) score (Appendix 
2), the total operating time, total anesthetic time, surgical 
condition, volume of crystalloid given and the use of ephedrine.
    Data were analyzed with the use of SAS
Ⓡ (version 9.2, SAS 
Institute, Cary, NC, USA). After normality test was conducted, 
age, volume, initial HR, BMI, operation time and anesthesia 
time, not showing normal distribution were examined with 
Kruskal-Wallis test, a non-parametric one-way ANOVA test and 
MBP at initial, 30 minutes and 60 minutes, HR at 30 minutes 
and 60 minutes with normal distribution were tested with 
ANOVA. As scores are ordinal scales, non-parametric analysis 
was performed, and Kruskal-Wallis test was conducted to 
determine differences of scores among the drugs. The friedman 
test was used to determine differences of scores following use 
of ephedrine and the spearman correlation test was performed 
to analyze the correlations of age, use of ephedrine and scores 
of each group, by using Fisher’s exact test. Comparisons were 
considered significant if P < 0.05.
Results
    Among the three groups, there were no significant differences 
in the mean total surgical time, nor were there significant 
differences in the characteristics of the patients, duration of 
operation, crystalloid requirement and use of ephedrine (Table 
1). The three groups were similar in terms of their mean LM CT 
score (Table 1). None of the groups had significant differences 
in MBP and HR throughout the operation (Table 2). There were 
no significant differences among the three groups for surgical 
grade score (Table 2).
Discussion
    To obtain a relatively bloodless field in order to optimize 
visibility for the surgeon, various maneuvers are commonly 
used [1,2,9-12]. The concept that anesthesia may contribute to 
blood loss during surgery is not new; Stankiewicz [13] reported 
that estimated blood loss was less in patients receiving local 
anesthesia as opposed to general anesthesia for endoscopic 
sinus surgery. Surgical condition has been reported, in a 
statistically significant manner, to be influenced by the type of 
anesthetics, BP and HR [2,9,10,12]. Traditionally, controlled 
Table 1. The Characteristics of Patients
Variables
PRO/REM
(n = 20)
SEVO/REM
(n = 20)
DES/REM
(n = 20)
P value
Age (yr)
Weight (kg)
Height (cm)
Sex (F/M)
BMI (kg/m
2)
LM CT score
Duration of anesthesia (min)
Duration of operation (min)
Use of ephedrine (n)
Crystalloid requirement (ml)
37 (19-58)
65 (47-85)
167 (154-182)
5/15
23.2 (18.9-30.7)
6.8 (2-14)
107 (80-160)
   83 (65-120)
8
642.5 (400-800)
43 (19-58)
64 (49-98)
  165 (153-183)
10/10
   23.5 (18.3-31.2)
6.1 (2-12)
109 (85-140)
  84 (70-120)
5
      670 (500-1,000)
43 (19-59)
65 (51-82)
  166 (150-182)
8/12
    23.2 (18.3-30.2)
6.70 (2-12)
108 (90-140)
  82 (60-110)
7
  677.5 (500-1,000)
 0.17
0.94
0.65
0.81
0.99
0.83
0.86
Values are number of patients (n) or medians (range). PRO: propofol, REM: remifentanil, SEVO: sevoflurane, DES: desflurane, F: female, M: 
male, LM CT: Lund-Mackay computed tomography.
Table 2. Mean Blood Pressure, Heart Rate and Surgical Grade Score
Variable
PRO/REM
(n = 20)
SEVO/REM
(n = 20)
DES/REM
(n = 20)
P value
Mean BP
Heart rate
Surgical grade score
Initial
30 min
60 min
Initial
30 min
60 min
91.3 ± 11.3
69.3 ± 6.7
69.3 ± 5.2
79.1 ± 13.2
77.1 ± 15.7
74.9 ± 11.8
2.05 (1-3)
91.1 ± 12.9
67.1 ± 5.7
67.2 ± 4.8
88.0 ± 21.8
77.1 ± 10.8
74.6 ± 10.7
2.21 (1-3)
92.2 ± 11.8
67.4 ± 6.0
67.3 ± 4.6
94.4 ± 20.0
78.2 ± 10.1
73.9 ± 12.1
2.07 (1-3)
0.95
0.47
0.30
0.81
0.95
0.96
0.82
Values are expressed as mean ± SEM or medians (range). Surgical grade score is measured at 60 minutes after the operation started. PRO: 
propofol, REM: remifentanil, SEVO: sevoflurane, DES: desflurane.380 www.ekja.org
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hypotension is required to reduce the amount of blood loss and 
provide a dry surgical field, but can cause some problems such 
as rebound hypertension, reflex tachycardia, vasodilation, organ 
ischemia and myocardial depression field for ESS. Further, the 
surgical field has not always been improved as a consequence 
of MBP reduction [7] and induced hypotension [8,14,15].
    Desflurane is known to cause a moderate rise in heart rate, 
central venous pressure, and pulmonary artery pressure 
which often does not become apparent at low doses. Cardiac 
output remains relatively unchanged or slightly depressed 
with desflurane at 1-2 MAC. Sevoflurane decreases systemic 
vascular resistance and arterial blood pressure slightly less than 
desflurane. Sevoflurane causes little, if any, rise in heartrate, and 
patient's cardiac output is not maintained as well as it is with 
desflurane [16]. Despite the slightly different cardiovascular 
system effects between these two inhalation agents, it is 
reported that desflurane, sevoflurane or isoflurane combined 
with remifentanil provided adequate induced hypotension 
(MAP 60-70 mmHg) and similar surgical conditions during 
tympanoplasty [17]. Similarly, there are no significant differences 
between SEV/REM and DES/REM groups in our study.
    Inhalation agents have a dose-dependent decrease in systemic 
vascular resistance which leads to the reduction in blood pressure 
[16]. This property can cause a capillary bleeding despite that 
systolic blood pressure is low [9]. Wormald et al. [3] suggest that 
the improvement in surgical grade in the TIVA group appears to 
be related to an overall reduction in MAP and the patients in the 
sevoflurane group require more significant reductions in MAP 
in order to obtain an equivalent surgical field grade score, due 
to the vasodilatory effect which results in capillary bleeding.
    Some studies have reported that propofol produces a 
better surgical field than inhalational anesthesia in patients 
undergoing ESS, irrespective of the complexity of surgery 
[2,3,9,18]. Propofol and opioids can depress cerebral blood 
flow in parallel with depression of cerebral metabolic rate [19]. 
Thus, reduction of cerebral blood flow with propofol would be 
expected to decrease blood flow to the ethmoid, sphenoid, and 
frontal sinuses and potentially diminish bleeding related to 
arterial inflow.
    It is well-known that remifentanil used in all three groups in 
our study provides excellent intraoperative analgesia and favors 
prompt emergence without prolonged respiratory depression 
[6,20,21]. The advantage of remifentanil in ESS is that they 
lower blood pressure through a decrease in cardiac output 
without peripheral vasodilatation, which results in reducing 
the capillary bleeding and at the same time provides good 
endoscopic surgical conditions [6]. The most frequent adverse 
events encountered when using remifentanil for IV anesthesia 
are hypotension during induction and hypotension and/or 
bradycardia during maintenance [10,22]. Although bradycardia 
is a recognized side effect of remifentanil [22], this was not 
a significant side effect in our study. In order to maintain 
controlled BP and HR, we did not allow the concomitant use of 
other cardiovascular medications other than ephedrine.
    In this study, the PRO/REM group showed no statistical 
difference in using cardiovascular medication (IV ephedrine 
in this study) when compared with the other groups (P = 0.83). 
Some needs were almost entirely due to the higher incidence of 
hypotension during the induction and the early maintenance 
phase of anesthesia (i.e., after position change and before the 
start of surgery). In such cases, no significant effect was noted 
with surgical grade score (P = 0.62). 
    Severity of chronic sinusitis is one of the factors which can 
affect surgical condition. Ahn et al. [4] reported that the patients 
with a low-LM score (≤12) were not affected by anesthetic 
methods. In contrast, TIVA resulted in a better surgical 
condition than conventional balanced anesthesia in the 
patients with a high-LM score (>12). In our study, there were 
no statistically significant differences in MBP (P = 0.30), HR (P 
= 0.96), and surgical grade scores (P = 0.82) among the three 
groups at 60 minutes after the initiation of the operation and 
this result may be due to low LM scores in all three groups.
    The operation time has also been reported as having an effect 
on the surgical field [3], which may be due to an increase in 
vasodilation with operation time as well as an increase in the 
surface area of the damaged tissue. In our study, we compared 
the surgical field score at 60 minutes after the initiation of the 
operation in all three groups to minimize the operation time 
factor which may contribute to the surgical field condition.
    In conclusion, among three different anesthetic combinations 
(PRO/REM, SEV/REM, and DES/REM) in patients undergoing 
ESS with controlled BP and HR, we did not observe any 
significant differences in the surgical grade scores. 
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Appendix 1. Surgical Grade Scoring System Designed Specifically for Use in Endoscopic Sinus Surgery
Grade Assessment 
0
1
2
3
4
5
No bleeding (cadaveric conditions)
Slight bleeding - no suctioning required
Slight bleeding - occasional suctioning required
Slight bleeding - frequent suctioning required; bleeding threatens surgical field a few seconds after suction is removed
Moderate bleeding - frequent suctioning required and bleeding threatens surgical field directly after suction is removed
Severe bleeding - constant suctioning required; bleeding appears faster than can be removed by suction; surgical field severely 
  threatened and surgery usually not possible
Appendix 2. Lund–Mackay Computed Tomography Staging System
No abnormality Partial opacification Total opacification
Anterior ethmoid
Posterior ethmoid
Maxillary
Frontal
Spehnoid
L
R
L
R
R
L
R
L
R
L
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
Non- obstructed Obstructed
Ostiomeatal  complex R
L
0
0
2
2